Company intelligence / Profile preview

Neuro Spinal Innovation

Mississauga, Ontario, Canadasonik.health ↗

Ownership: Private
Development stage: Other

Overview

The company's lead product, the SONIK MONARK 100 device, has received Health Canada approval for prototype testing and has been submitted for FDA clearance. It uses focused vibroacoustic therapy to treat chronic back and neck pain non-invasively. Early results indicate substantial equivalence to a predicate device (KKT-M2), with improvements in portability and usability.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyVibroacoustic therapy device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Neuro Spinal Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro Spinal Innovation.

Explore the full profile